Rep. Maurice A. West, II

Filed: 2/18/2026

 

 


 

 


 
10400HB3286ham002LRB104 11199 JRC 34490 a

1
AMENDMENT TO HOUSE BILL 3286

2    AMENDMENT NO. ______. Amend House Bill 3286 by replacing
3everything after the enacting clause with the following:
 
4    "Section 5. The Substance Use Disorder Act is amended by
5changing Section 30-5 as follows:
 
6    (20 ILCS 301/30-5)
7    Sec. 30-5. Patients' rights established.
8    (a) For purposes of this Section, "patient" means any
9person who is receiving or has received early intervention,
10treatment, or other recovery support services under this Act
11or any category of service licensed as "intervention" under
12this Act.
13    (b) No patient shall be deprived of any rights, benefits,
14or privileges guaranteed by law, the Constitution of the
15United States of America, or the Constitution of the State of
16Illinois solely because of his or her status as a patient.

 

 

10400HB3286ham002- 2 -LRB104 11199 JRC 34490 a

1    (c) Persons who have substance use disorders who are also
2suffering from medical conditions shall not be discriminated
3against in admission or treatment by any hospital that
4receives support in any form supported in whole or in part by
5funds appropriated to any State department or agency.
6    (d) Every patient shall have impartial access to services
7without regard to race, religion, sex, ethnicity, age, sexual
8orientation, gender identity, marital status, or other
9disability.
10    (e) Patients shall be permitted the free exercise of
11religion.
12    (f) Every patient's personal dignity shall be recognized
13in the provision of services, and a patient's personal privacy
14shall be assured and protected within the constraints of his
15or her individual treatment.
16    (g) Treatment services shall be provided in the least
17restrictive environment possible.
18    (h) Each patient receiving treatment services shall be
19provided an individual treatment plan, which shall be
20periodically reviewed and updated as mandated by
21administrative rule.
22    (i) Treatment shall be person-centered, meaning that every
23patient shall be permitted to participate in the planning of
24his or her total care and medical treatment to the extent that
25his or her condition permits.
26    (j) A person shall not be denied treatment solely because

 

 

10400HB3286ham002- 3 -LRB104 11199 JRC 34490 a

1he or she has withdrawn from treatment against medical advice
2on a prior occasion or had prior treatment episodes.
3    (k) The patient in residential treatment shall be
4permitted visits by family and significant others, unless such
5visits are clinically contraindicated.
6    (l) A patient in residential treatment shall be allowed to
7conduct private telephone conversations with family and
8friends unless clinically contraindicated.
9    (m) A patient in residential treatment shall be permitted
10to send and receive mail without hindrance, unless clinically
11contraindicated.
12    (n) A patient shall be permitted to manage his or her own
13financial affairs unless the patient or the patient's
14guardian, or if the patient is a minor, the patient's parent,
15authorizes another competent person to do so.
16    (o) A patient shall be permitted to request the opinion of
17a consultant at his or her own expense, or to request an
18in-house review of a treatment plan, as provided in the
19specific procedures of the provider. A treatment provider is
20not liable for the negligence of any consultant.
21    (p) Unless otherwise prohibited by State or federal law,
22every patient shall be permitted to obtain from his or her own
23physician, the treatment provider, or the treatment provider's
24consulting physician complete and current information
25concerning the nature of care, procedures, and treatment that
26he or she will receive.

 

 

10400HB3286ham002- 4 -LRB104 11199 JRC 34490 a

1    (q) A patient shall be permitted to refuse to participate
2in any experimental research or medical procedure without
3compromising his or her access to other, non-experimental
4services. Before a patient is placed in an experimental
5research or medical procedure, the provider must first obtain
6his or her informed written consent or otherwise comply with
7the federal requirements regarding the protection of human
8subjects contained in 45 CFR Part 46.
9    (r) All medical treatment and procedures shall be
10administered as ordered by a physician and in accordance with
11all Department rules.
12    (s) Every patient in treatment shall be permitted to
13refuse medical treatment and to know the consequences of such
14action. Such refusal by a patient shall free the treatment
15licensee from the obligation to provide the treatment.
16    (t) Unless otherwise prohibited by State or federal law,
17every patient, patient's guardian, or parent, if the patient
18is a minor, shall be permitted to inspect and copy all clinical
19and other records kept by the intervention or treatment
20licensee or by his or her physician concerning his or her care
21and maintenance. The licensee or physician may charge a
22reasonable fee for the duplication of a record.
23    (u) No owner, licensee, administrator, employee, or agent
24of a licensed intervention or treatment program shall abuse or
25neglect a patient. It is the duty of any individual who becomes
26aware of such abuse or neglect to report it to the Department

 

 

10400HB3286ham002- 5 -LRB104 11199 JRC 34490 a

1immediately.
2    (v) The licensee may refuse access to any person if the
3actions of that person are or could be injurious to the health
4and safety of a patient or the licensee, or if the person seeks
5access for commercial purposes.
6    (w) All patients admitted to community-based treatment
7facilities shall be considered voluntary treatment patients
8and such patients shall not be contained within a locked
9setting.
10    (x) Patients and their families or legal guardians shall
11have the right to present complaints to the provider or the
12Department concerning the quality of care provided to the
13patient, without threat of discharge or reprisal in any form
14or manner whatsoever. The complaint process and procedure
15shall be adopted by the Department by rule. The treatment
16provider shall have in place a mechanism for receiving and
17responding to such complaints, and shall inform the patient
18and the patient's family or legal guardian of this mechanism
19and how to use it. The provider shall analyze any complaint
20received and, when indicated, take appropriate corrective
21action. Every patient and his or her family member or legal
22guardian who makes a complaint shall receive a timely response
23from the provider that substantively addresses the complaint.
24The provider shall inform the patient and the patient's family
25or legal guardian about other sources of assistance if the
26provider has not resolved the complaint to the satisfaction of

 

 

10400HB3286ham002- 6 -LRB104 11199 JRC 34490 a

1the patient or the patient's family or legal guardian.
2    (y) A patient may refuse to perform labor at a program
3unless such labor is a part of the patient's individual
4treatment plan as documented in the patient's clinical record.
5    (z) A person who is in need of services may apply for
6voluntary admission in the manner and with the rights provided
7for under regulations promulgated by the Department. If a
8person is refused admission, then staff, subject to rules
9promulgated by the Department, shall refer the person to
10another facility or to other appropriate services.
11    (aa) No patient shall be denied services based solely on
12HIV status. Further, records and information governed by the
13AIDS Confidentiality Act and the AIDS Confidentiality and
14Testing Code (77 Ill. Adm. Code 697) shall be maintained in
15accordance therewith.
16    (bb) Records of the identity, diagnosis, prognosis or
17treatment of any patient maintained in connection with the
18performance of any service or activity relating to substance
19use disorder education, early intervention, intervention,
20training, or treatment that is regulated, authorized, or
21directly or indirectly assisted by any Department or agency of
22this State or under any provision of this Act shall be
23confidential and may be disclosed only in accordance with the
24provisions of federal law and regulations concerning the
25confidentiality of substance use disorder patient records as
26contained in 42 U.S.C. Sections 290dd-2 and 42 CFR Part 2, or

 

 

10400HB3286ham002- 7 -LRB104 11199 JRC 34490 a

1any successor federal statute or regulation.
2        (1) The following are exempt from the confidentiality
3    protections set forth in 42 CFR Section 2.12(c):
4            (A) Veteran's Administration records.
5            (B) Information obtained by the Armed Forces.
6            (C) Information given to qualified service
7        organizations.
8            (D) Communications within a program or between a
9        program and an entity having direct administrative
10        control over that program.
11            (E) Information given to law enforcement personnel
12        investigating a patient's commission of a crime on the
13        program premises or against program personnel.
14            (F) Reports under State law of incidents of
15        suspected child abuse and neglect; however,
16        confidentiality restrictions continue to apply to the
17        records and any follow-up information for disclosure
18        and use in civil or criminal proceedings arising from
19        the report of suspected abuse or neglect.
20        (2) If the information is not exempt, a disclosure can
21    be made only under the following circumstances:
22            (A) With patient consent as set forth in 42 CFR
23        Sections 2.1(b)(1) and 2.31, and as consistent with
24        pertinent State law.
25            (B) For medical emergencies as set forth in 42 CFR
26        Sections 2.1(b)(2) and 2.51.

 

 

10400HB3286ham002- 8 -LRB104 11199 JRC 34490 a

1            (C) For research activities as set forth in 42 CFR
2        Sections 2.1(b)(2) and 2.52.
3            (D) For audit evaluation activities as set forth
4        in 42 CFR Section 2.53.
5            (E) With a court order as set forth in 42 CFR
6        Sections 2.61 through 2.67.
7            (F) In response to a request made under the
8        Domestic Violence Fatality Review Act but only to the
9        extent not otherwise subject to 42 CFR Part 2.
10        (3) The restrictions on disclosure and use of patient
11    information apply whether the holder of the information
12    already has it, has other means of obtaining it, is a law
13    enforcement or other official, has obtained a subpoena, or
14    asserts any other justification for a disclosure or use
15    that is not permitted by 42 CFR Part 2. Any court orders
16    authorizing disclosure of patient records under this Act
17    must comply with the procedures and criteria set forth in
18    42 CFR Sections 2.64 and 2.65. Except as authorized by a
19    court order granted under this Section, no record referred
20    to in this Section may be used to initiate or substantiate
21    any charges against a patient or to conduct any
22    investigation of a patient.
23        (4) The prohibitions of this subsection shall apply to
24    records concerning any person who has been a patient,
25    regardless of whether or when the person ceases to be a
26    patient.

 

 

10400HB3286ham002- 9 -LRB104 11199 JRC 34490 a

1        (5) Any person who discloses the content of any record
2    referred to in this Section except as authorized shall,
3    upon conviction, be guilty of a Class A misdemeanor.
4        (6) The Department shall prescribe regulations to
5    carry out the purposes of this subsection. These
6    regulations may contain such definitions, and may provide
7    for such safeguards and procedures, including procedures
8    and criteria for the issuance and scope of court orders,
9    as in the judgment of the Department are necessary or
10    proper to effectuate the purposes of this Section, to
11    prevent circumvention or evasion thereof, or to facilitate
12    compliance therewith.
13    (cc) Each patient shall be given a written explanation of
14all the rights enumerated in this Section and a copy, signed by
15the patient, shall be kept in every patient record. If a
16patient is unable to read such written explanation, it shall
17be read to the patient in a language that the patient
18understands. A copy of all the rights enumerated in this
19Section shall be posted in a conspicuous place within the
20program where it may readily be seen and read by program
21patients and visitors.
22    (dd) The program shall ensure that its staff is familiar
23with and observes the rights and responsibilities enumerated
24in this Section.
25    (ee) Licensed organizations shall comply with the right of
26any adolescent to consent to treatment without approval of the

 

 

10400HB3286ham002- 10 -LRB104 11199 JRC 34490 a

1parent or legal guardian in accordance with the Consent by
2Minors to Health Care Services Act.
3    (ff) At the point of admission for services, licensed
4organizations must obtain written informed consent, as defined
5in Section 1-10 and in administrative rule, from each client,
6patient, or legal guardian.
7(Source: P.A. 102-813, eff. 5-13-22.)
 
8    Section 10. The Mental Health and Developmental
9Disabilities Confidentiality Act is amended by changing
10Section 7 as follows:
 
11    (740 ILCS 110/7)  (from Ch. 91 1/2, par. 807)
12    Sec. 7. Review of therapist or agency; use of recipient's
13record.
14    (a) When a therapist or agency which provides services is
15being reviewed for purposes of licensure, statistical
16compilation, research, evaluation, or other similar purpose, a
17recipient's record may be used by the person conducting the
18review to the extent that this is necessary to accomplish the
19purpose of the review, provided that personally identifiable
20data is removed from the record before use. Personally
21identifiable data may be disclosed only in accordance with
22Section 5 of this Act. Licensure and the like may not be
23withheld or withdrawn for failure to disclose personally
24identifiable data if consent is not obtained.

 

 

10400HB3286ham002- 11 -LRB104 11199 JRC 34490 a

1    (b) When an agency which provides services is being
2reviewed for purposes of funding, accreditation, reimbursement
3or audit by a State or federal agency or accrediting body, a
4recipient's record may be used by the person conducting the
5review and personally identifiable information may be
6disclosed without consent, provided that the personally
7identifiable information is necessary to accomplish the
8purpose of the review.
9    For the purpose of this subsection, an inspection
10investigation or site visit by the United States Department of
11Justice regarding compliance with a pending consent decree is
12considered an audit by a federal agency.
13    (c) An independent team of experts under Brian's Law shall
14be entitled to inspect and copy the records of any recipient
15whose death is being examined by such a team pursuant to the
16mortality review process authorized by Brian's Law.
17Information disclosed under this subsection may not be
18redisclosed without the written consent of one of the persons
19identified in Section 4 of this Act.
20    (d) Staff and any designee of the Illinois Criminal
21Justice Information Authority, members of the Ad Hoc Statewide
22Domestic Violence Fatality Review Committee of the Illinois
23Criminal Justice Information Authority Board, and the regional
24domestic violence fatality review teams are entitled to
25receive, inspect, copy, and share the records covered by this
26Act of any recipient subject to a domestic violence fatality

 

 

10400HB3286ham002- 12 -LRB104 11199 JRC 34490 a

1review, including, but not limited to, a recipient who
2experienced or caused a near-fatality or fatality related to
3domestic violence, for the purposes of domestic violence
4fatality review and in accordance with the responsibilities
5required and authorized by the Domestic Violence Fatality
6Review Act. Information disclosed under this Section is
7subject to the confidentiality requirements of the Domestic
8Violence Fatality Review Act.
9(Source: P.A. 98-378, eff. 8-16-13.)
 
10    Section 99. Effective date. This Act takes effect upon
11becoming law.".